High Dietary Fat Modulates Neurobehavioural Effect of Lopinavir/ Ritonavir in Mice.
Onaolapo OJ, Adeyemi OI, Amujoyegbe OJ, Fasola EA, Olofinnade AT, Onaolapo AY.
Curr Pharm Biotechnol · journal article · DOI 10.2174/1389201020666191011144930 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för Kaletra. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
23 träffarEfficacy and Tolerability of Lopinavir/Ritonavir- and Efavirenz-Based Initial Antiretroviral Therapy in HIV-1-Infected Patients in a Tertiary Care Hospital in Beijing, China.
Su B, Wang Y, Zhou R, Jiang T, Zhang H, Li Z, Liu A, Shao Y, Hua W, Zhang T, Wu H, He S, Dai L, Sun L.
Front Pharmacol · research-article; journal article · DOI 10.3389/fphar.2019.01472Evaluation of super-boosted lopinavir/ritonavir in combination with rifampicin in HIV-1-infected patients with tuberculosis.
Boulanger C, Rolla V, Al-Shaer MH, Peloquin C.
Int J Antimicrob Agents · clinical trial; journal article · DOI 10.1016/j.ijantimicag.2019.10.021Inflammatory biomarker levels over 48 weeks with dual vs triple lopinavir/ritonavir-based therapy: Substudy of a randomized trial.
Tan DHS, Rolon MJ, Figueroa MI, Sued O, Gun A, Kaul R, Raboud JM, Szadkowski L, Hull MW, Walmsley SL, Cahn P, Argentinean GARDEL research network.
PLoS One · comparative study; research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0221653Safety and efficacy of rifabutin among HIV/TB-coinfected children on lopinavir/ritonavir-based ART.
Rawizza HE, Darin KM, Oladokun R, Brown B, Ogunbosi B, David N, Akanmu S, Olaitan O, Chang C, Scarsi KK, Okonkwo P, Kanki PJ.
J Antimicrob Chemother · research support, u.s. gov't, p.h.s.; research-article; journal article; research support, n.i.h., extramural · DOI 10.1093/jac/dkz219Pharmacokinetics of adjusted-dose 8-hourly lopinavir/ritonavir in HIV-infected children co-treated with rifampicin.
Rabie H, Rawizza H, Zuidewind P, Winckler J, Zar H, Van Rie A, Wiesner L, McIlleron H.
J Antimicrob Chemother · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1093/jac/dkz171Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency Virus.
Desmonde S, Frank SC, Coovadia A, Dahourou DL, Hou T, Abrams EJ, Amorissani-Folquet M, Walensky RP, Strehlau R, Penazzato M, Freedberg KA, Kuhn L, Leroy V, Ciaranello AL.
Open Forum Infect Dis · research-article; journal article · DOI 10.1093/ofid/ofz276An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir.
Laker EAO, Nabaggala MS, Kaimal A, Nalwanga D, Castelnuovo B, Musubire A, Kiragga A, Lamorde M, Ratanshi RP.
BMC Infect Dis · research-article; journal article; observational study · DOI 10.1186/s12879-019-3907-5Growth in HIV-1-exposed but uninfected infants treated with lopinavir-ritonavir versus lamivudine: a secondary analysis of the ANRS 12174 trial.
Blanche S, Tylleskär T, Peries M, Kankasa C, Engebretsen I, Meda N, Tumwine JK, Singata-Madliki M, Mwiya M, Van de Perre P, Nagot N, ANRS 12174 Trial Group.
Lancet HIV · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1016/s2352-3018(18)30361-8HIV Viral Dynamics of Lopinavir/Ritonavir Monotherapy as Second-Line Treatment: A Prospective, Single-Arm Trial.
Claassen CW, Keckich D, Nwizu C, Abimiku A, Salami D, Obiefune M, Gilliam BL, Amoroso A.
J Int Assoc Provid AIDS Care · clinical trial; research support, non-u.s. gov't; research-article; journal article · DOI 10.1177/2325958218823209Comparative Assessment of the Magnitude of Hyperlipidemia in HIV-Infected Patients Receiving Lopinavir/r- and Atazanavir/r-Based Antiretroviral Drugs.
Muya E, Kamuhabwa A.
J Int Assoc Provid AIDS Care · comparative study; research-article; journal article · DOI 10.1177/2325958219841908Assessing the adoption of lopinavir/ritonavir oral pellets for HIV-positive children in Zimbabwe.
Pasipanodya B, Kuwengwa R, Prust ML, Stewart B, Chakanyuka C, Murimwa T, Brophy J, Salami O, Mushavi A, Apollo T.
J Int AIDS Soc · brief-report; journal article · DOI 10.1002/jia2.25214Population pharmacokinetics and dosing regimen optimisation of lopinavir in Chinese adults infected with HIV.
Niu WJ, Sun T, Liu L, Liu XQ, Zhang RF, Yin L, Wang JR, Jia XF, Lu HZ, Zhong MK, Jiao Z, Jiao Z, Zhang LJ.
Basic Clin Pharmacol Toxicol · journal article · DOI 10.1111/bcpt.13154Assessing the Efficacy of Lopinavir/Ritonavir-Based Preferred and Alternative Second-Line Regimens in HIV-Infected Patients: A Meta-Analysis of Key Evidence to Support WHO Recommendations.
Huang Y, Huang X, Luo Y, Zhou Y, Tao X, Chen H, Song A, Chen Y, Wu H.
Front Pharmacol · review-article; review; journal article · DOI 10.3389/fphar.2018.00890Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women.
Ribeiro RMP, Moreira FL, Moisés ECD, Cavalli RC, Quintana SM, Lanchote VL, Duarte G.
Br J Clin Pharmacol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1111/bcp.13700Week 96 efficacy of lopinavir/ritonavir monotherapy in virologically suppressed patients with HIV: a randomized non-inferiority trial (ANRS 140 DREAM).
Meynard JL, Moinot L, Landman R, Morand-Joubert L, Besseghir A, Kolta S, Spire B, Todesco E, Bouchaud O, Fagard C, Chene G, Girard PM, ANRS 140 DREAM Study Group.
J Antimicrob Chemother · clinical trial, phase iii; clinical trial, phase ii; equivalence trial; research support, non-u.s. gov't; journal article · DOI 10.1093/jac/dky055Tenofovir disoproxil fumarate co-administered with lopinavir/ritonavir is strongly associated with tubular damage and chronic kidney disease.
Mizushima D, Nguyen DTH, Nguyen DT, Matsumoto S, Tanuma J, Gatanaga H, Trung NV, van Kinh N, Oka S.
J Infect Chemother · journal article; observational study · DOI 10.1016/j.jiac.2018.03.002Estradiol Levels Are Altered in Human Immunodeficiency Virus-Infected Pregnant Women Randomized to Efavirenz-Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy.
McDonald CR, Conroy AL, Gamble JL, Papp E, Hawkes M, Olwoch P, Natureeba P, Kamya M, Silverman M, Cohan D, Koss CA, Dorsey G, Kain KC, Serghides L.
Clin Infect Dis · research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.1093/cid/cix772Prediction of area under the concentration-time curve for lopinavir from peak or trough lopinavir concentrations in patients receiving lopinavir-ritonavir therapy.
Srinivas NR.
Am J Health Syst Pharm · review; journal article · DOI 10.2146/ajhp150417Maraviroc 150 mg daily plus lopinavir/ritonavir, a nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimen for HIV-infected naive patients: 48-week final results of VEMAN study.
Nozza S, Galli L, Antinori A, Chiappetta S, Mazzotta F, Zaccarelli M, Ottou S, De Battista D, Pogliaghi M, Di Pietro M, Malnati M, Ripa M, Bonora S, Lazzarin A, VEMAN Study Group.
Clin Microbiol Infect · comparative study; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.cmi.2014.12.006Achilles tendinopathy following Kaletra (lopinavir/ritonavir) use.
Cresswell FV, Tomlins J, Churchill DR, Walker-Bone K, Richardson D.
Int J STD AIDS · journal article; case reports · DOI 10.1177/0956462414523403Kaletra oral solution: modification of confusing label: packaging. an infant died in France.
Författaruppgift saknas
Prescrire Int · journal article; case reportsKaletra single agent HAART after intolerance of NRTI- and NNRTI-containing regimens following kidney transplantation.
Schürmann D, Wesselmann H, Kurowski M, Suttorp N, Reinke P.
Infection · journal article; case reports · DOI 10.1007/s15010-007-6084-1